Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy
- PMID: 28102146
- DOI: 10.1016/S1474-4422(16)30382-9
Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
